Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

PharmaResearch clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Singapore and South Korea registers with PharmaResearch as lead sponsor. Synced 5 Nov 2026
3Current trials
0Recruiting now
0Drugs in these trials
2Trial registers
At a glance

PharmaResearch is the lead sponsor of 3 current clinical trials in our Singapore and South Korea registers. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Observational. The most-studied condition is Skin Aging.

ClinicalTrials.gov trials by status

  • Not yet open267%
  • By invitation133%

Trials by phase

  • Observational267%
  • Phase 3133%
01

Clinical trials sponsored by PharmaResearch

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)
NCT07912879 · ClinicalTrials.gov ↗ · Skin Aging, Horizontal Neck Lines
Observational Not yet open 2026-11 Singapore
Clinical Research on Deep-Plane Rejuran S Injection for Improvement in the Apperance of Periorbital Hollowing Using a Cannula Technique
NCT07912814 · ClinicalTrials.gov ↗ · Periorbital Hollowing, Skin Aging
Observational Not yet open 2026-12 Singapore
Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.
NCT06779071 · ClinicalTrials.gov ↗ · Knee Osteoarthritis
Phase 3 By invitation 2025-01 South Korea

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in PharmaResearch trials

4 conditions
Skin Aging2Knee Osteoarthritis1Horizontal Neck Lines1Periorbital Hollowing1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Singapore20
Clinical trials in South Korea10

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Skin Aging

SponsorTrials
IBSA Farmaceutici Italia1

Sponsors with the most current trials registered for this condition.

05

Questions about PharmaResearch trials

How many clinical trials does PharmaResearch sponsor?

PharmaResearch is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Singapore and South Korea registers, as of the registry sync on 5 November 2026. Completed and withdrawn studies are not counted.

Are PharmaResearch trials recruiting?

Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 5 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.